Apr 9 |
NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study
|
Mar 28 |
Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
|
Mar 20 |
NuCana: Q4 Earnings Insights
|
Mar 20 |
NuCana GAAP EPS of -£0.14
|
Mar 20 |
NuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update
|
Mar 13 |
Dow Surges Over 100 Points; Dollar Tree Earnings Miss Expectations
|
Feb 27 |
NuCana to Present at TD Cowen’s 44th Annual Health Care Conference
|
Feb 6 |
NuCana to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
|
Jan 3 |
NuCana: Potential Turnaround In 2024 But Risky
|
Nov 16 |
NuCana GAAP EPS of -£0.13
|